QVM149
QVM149 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Anti-inflammatory Effects Glycopyrronium
Investigating the Effects of QVM149 on MRI Ventilation Defects
Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium
A Long-term Safety Study of QVM149 in Japanese Patients With Asthma
Clinical Trials (5)
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Anti-inflammatory Effects Glycopyrronium
Investigating the Effects of QVM149 on MRI Ventilation Defects
Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium
A Long-term Safety Study of QVM149 in Japanese Patients With Asthma
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5